Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 706 AL 720

Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker

Jacobs HI, Radua J, Lückmann HC, Sack AT.

Neurosci Biobehav Rev. 2013 Jun;37(5):753-65. doi: 10.1016/j.neubiorev.2013.03.009. Epub 2013 Mar 21.

Alzheimer's disease: connecting findings from graph theoretical studies of brain networks

Tijms BM, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F.

Neurobiol Aging. 2013 Aug;34(8):2023-36. doi: 10.1016/j.neurobiolaging.2013.02.020. Epub 2013 Mar 28.

Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele

Qiu WW, Lai A, Mon T, Mwamburi M, Taylor W, Rosenzweig J, Kowall N, Stern R, Zhu H, Steffens DC.

Am J Geriatr Psychiatry. 2014 Feb;22(2):177-85. doi: 10.1016/j.jagp.2012.08.017. Epub 2013 Apr 3.

Vascular contribution to Alzheimer disease: predictors of rapid progression

Diomedi M, Misaggi G.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):532-7. doi: 10.2174/1871527311312040015.

Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis

Liu SY, Zeng FF, Chen ZW, Wang CY, Zhao B, Li KS.

CNS Neurosci Ther. 2013 Jul;19(7):469-76. doi: 10.1111/cns.12093. Epub 2013 Apr 10.

Decisive role of Reelin signaling during early stages of Alzheimer's disease

Krstic D, Pfister S, Notter T, Knuesel I.

Neuroscience. 2013 Aug 29;246:108-16. doi: 10.1016/j.neuroscience.2013.04.042. Epub 2013 Apr 28.

Exploring sleep-related outcomes in patients with mild to moderate Alzheimer's disease initiating acetylcholinesterase inhibitor therapy: the Morpheus survey

Petiau C, Onen H, Delgado A, Touchon J.

Int J Geriatr Psychiatry. 2013 Jun;28(6):657-9. doi: 10.1002/gps.3896.

Association between EXOC3L2 rs597668 polymorphism and Alzheimer's disease

Shang H, Fu J, Zhang XM, Song RR, Wang WZ.

CNS Neurosci Ther. 2013 Oct;19(10):834-9. doi: 10.1111/cns.12119. Epub 2013 May 11.

Wrist actigraphy for measuring sleep in intervention studies with Alzheimer's disease patients: application, usefulness, and challenges

Camargos EF, Louzada FM, Nóbrega OT.

Sleep Med Rev. 2013 Dec;17(6):475-88. doi: 10.1016/j.smrv.2013.01.006. Epub 2013 May 10.

Alzheimer's disease and glaucoma: mechanistic similarities and differences

Ghiso JA, Doudevski I, Ritch R, Rostagno AA.

J Glaucoma. 2013 Jun-Jul;22 Suppl 5(0 5):S36-8. doi: 10.1097/IJG.0b013e3182934af6.

Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus

Gordon BA, Blazey T, Benzinger TL, Head D.

J Alzheimers Dis. 2013;37(1):41-50. doi: 10.3233/JAD-130011.

Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease

Hatz F, Benz N, Hardmeier M, Zimmermann R, Rueegg S, Schindler C, Miserez AR, Gschwandtner U, Monsch AU, Fuhr P.

Clin Neurophysiol. 2013 Nov;124(11):2146-52. doi: 10.1016/j.clinph.2013.04.339. Epub 2013 Jun 17.

Brain Metabolic Dysfunction in Capgras Delusion During Alzheimer's Disease: A Positron Emission Tomography Study

Jedidi H, Daury N, Capa R, Bahri MA, Collette F, Feyers D, Bastin C, Maquet P, Salmon E.

Am J Alzheimers Dis Other Demen. 2015 Nov;30(7):699-706. doi: 10.1177/1533317513495105. Epub 2013 Jun 30.

The body-mind connection in aging and dementia

Larson EB.

J Am Geriatr Soc. 2013 Jul;61(7):1210-1. doi: 10.1111/jgs.12257.

Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study

Lebedev AV, Beyer MK, Fritze F, Westman E, Ballard C, Aarsland D.

Am J Geriatr Psychiatry. 2014 Jan;22(1):4-13.e1. doi: 10.1016/j.jagp.2013.02.004. Epub 2013 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias